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 Overview
± Basic theory and key assumptions
 Brief history
 Review commonly used instruments in health economics
 :KDW¶Vthe future for IV in applied health econometrics?
Background
 Instrumental Variables (IV) is a method for estimating consistent 
parameters when assumptions of classical models are violated
 In modern day econometrics, the principal use of IV is to address the 
problem of omitted variables bias
± ³&DXVDOLQIHUHQFHKDVDOZD\VEHHQWKHQDPHRIWKHJDPHLQDSSOLHG
HFRQRPHWULFV´$QJULVWDQGPischke, 2009)
± Potentially powerful tool for analysing observational data when 
RCTs are not feasible, desirable, practical or ethical
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Endogeneity
 Association between X1 and u if X3 is unobserved
 Failure of the zero conditional mean assumption E[u|x] = 0
 OLS inconsistent
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X1
X2
X3
u
Y
Z
Instrumental variable
 Z must be associated with X1
 Z must not be associated with u
X1
X2
X3
u
Y
Z
First stage
 Regress (endogenous X1) on Z
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 Use the predicted values of X1 to estimate Y
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Two critical assumptions
 There must be no association between Z and u (validity)
± This cannot be demonstrated using the data
± Researchers must appeal to existing theory and evidence
 There must be sufficient correlation between Z and X1 (the first stage)
± This can be proven using the data
± However, in many empirical examples, if the first stage relationship 
is very strong, then the validity of the instrument is likely to become 
less tenable without further evidence
 See Stock (2002)
A brief history
 Formal development of IV as a statistical method during the 1940s and 
1950s
± For example, H. Theil paper on two stage least squares published in 
1953
 Use of IV in health economics started in the 1990s
± Since then, interest in IV has grown
Cumulative number of studies listed in 
Medline and Embase that used (non-
genetic) IV analysis for medical 
research over time (Davies, 2013)
The challenge is finding good instruments
³2XUview is that progress in the application of instrumental variables methods 
depends mostly on the gritty work of finding or creating plausible experiments 
that can be used to measure important economic relationships.
³+HUHthe challenges are not primarily technical in the sense of requiring new 
theorems or estimators. Rather, progress comes from detailed institutional 
knowledge and the careful investigation and quantification of the forces at work in a 
particular setting. 
³2Icourse, such endeavours are not really new. They have always been at the 
heart of good HPSLULFDOUHVHDUFK´
The visionaries
 :LWKKLQGVLJKWLW¶VFOHDUWKDWVRPHHDUOLHU
researchers had fully understood the IV mechanisms
 Philip (or Sewall) Wright (1928) 
± Observed prices (x) and quantity demanded (y) 
are determined by the intersection of the supply 
and demand curves
± Wanted to estimate the slope of the demand and 
supply curves for butter and flaxseed
± An instrument for exogenous variation in supply 
was change in the weather (which affected crop 
growth but not product demand)
 Hidden in Appendix B of a long report on 
agriculture and farming
 John Snow (1855)
± For further discussion see Grootendorst (2007) 
Snow (1855)
 John Snow (On the mode of the communication of cholera, 1855) used 
IV to investigate the hypothesis that cholera was waterborne, in contrast 
to other theories that it was airborne
 Observed correlation between water purity (X1) and cholera incidence 
(y) 
 Problem:  People drinking impure water were also more likely to be poor 
and living in unhealthy environments (X3s)
 Solution:  Instrument (z) for pure water must be uncorrelated with other 
(observed and unobserved) determinants of cholera incidence
IV = The water supplier
 People living in green area were served by the Southwark and Vauxhall 
Water Company
 The pink area by the Lambeth Water Company
 In 1849, both companies obtained their water from Central London
 In 1852, the Lambeth company moved its waterworks upriver to an area 
relatively free of sewage
 Death rates from cholera transmission during the London cholera 
epidemic 1853-54 in districts supplied by Lambeth were significantly 
different to those supplied by Southwark and Vauxhall
1994
x
McClellan et al (1994)
 McClellan et al (1994) used IV to estimate the effect on mortality of 
intensive treatment of heart attack (using e.g. catheterisation or CABG)
 Correlation between heart attack treatment (X1) and mortality (y), even 
after controlling for observables (X2s)
 Problem:  Whether or not patient receives more intensive treatment is, 
of course, correlated with unobserved factors that affect mortality (X3s)
IV = Distance to specialist hospital
 Solution:  Instrument (z) for intensive treatment was differential distance 
to hospitals offering the intensive treatment
 Instrument relevance condition/first stage: Patients who live closer to 
hospitals that use more intensive treatments are more likely receive 
those treatments
IV = Distance to specialist hospital
 Instrument exogeneity condition/exclusion restriction:  Distance the 
patient lives from a hospital must be independent of the health status
 This can only be demonstrated for observable characteristics; the 
authors must convince the reader that it also holds for unobservables!
Naïve results overestimated the 
impact
 IV estimates of the impact of catheterisation on mortality are 
considerably smaller than estimates that did not account for selection 
bias
 ³$UHGLUHFWLRQRIUHVRXUFHVIURPPDUJLQDOFDWKHWHULVDWLRQVDQG
revascularisations to characterising and improving access to some 
[other] acute treatments could improve AMI mortality in the elderly and 
PD\UHGXFHFRVWV´
Finding more instruments
x
2000 onwards
 Distance
± To healthcare facility
 McConnell (2005) and Pracht (2008) used differential distance 
between the nearest level I and level II trauma treatment centres
± To other determinants of health
 Zhao (2010) used distance from motorway junctions as 
instrument for location of fast food restaurants
 Courtemanche (2011) used distance from Walmart headquarters 
as instrument for access to cheaper groceries
± For similar examples, see review:  Martin (2014)
 Personal beliefs
 Auld (2005) used religiosity as an instrument for alcohol use
 Calendar time 
 Ho (2000) used day of the week of hospital admission for wait 
time for surgery (many physicians work only on week days)
2000 onwards
 Exogenous shocks
± Sudden shifts in patient or physician behaviour
 Shetty (2010) used publication of unexpected results in an RCT 
which led to sharp fall in hormone replacement therapy (HRT) 
use
 Jenson (2015) used publication of unexpected results which led 
to sharply altered caesarean section rates for breech babies
± Also NQRZQDVµ)X]]\¶UHJUHVVLRQGLVFRQWLQXLW\GHVLJQ5''
 State laws, taxes, policies and prices
 Leigh (2004) used state-specific cigarette taxes as an instrument 
for smoking
 Tonne (2010) used the London congestion charge zone as an 
instrument for exposure to traffic-related air pollution
 Other studies have used differences in the minimum legal 
drinking age as an instrument for (illegal) alcohol consumption
More recent developments
x
x
x
Cawley (2012)
 Cawley and Meyerhoefer (2012) used IV to investigate impact of obesity 
on medical expenses in the U.S.
 Observed correlation between obesity (X1) and medical expenses (y)
Cawley (2012)
 Problem:  Obesity is likely to be associated with other factors that affect 
medical costs (X3s)
± People who have suffered a recent injury or chronic depression may 
have higher medical expenses and increased likelihood of obesity
 Observed correlation between obesity and medical expenses 
would be an overestimate of the true causal effect
± People with poorer access to healthcare, including the 
disadvantaged or poor, may be more likely to be obese
 Observed correlation between obesity and medical expenses 
would be an underestimate of the true causal effect
IV = Weight of own child
 6ROXWLRQ,QVWUXPHQW]IRULQGLYLGXDO¶VERG\ZHLJKWZDV%0,%0,
squared and BMI cubed of oldest biological child
± Extensive evidence showing relationship between own BMI and BMI 
of biological relatives
 Instrument validity:  extensive existing research showing no relationship 
between shared household environment on weight
± For example, adoption studies consistently show that correlation 
between a child and its biological parents is comparable for children 
raised by their biological parents and children raised by adoptive 
parents
Non linear relationship
Naïve results underestimated the 
impact
 IV estimates of the impact of obesity on medical costs were 
considerably larger than estimates that did not account for endogeneity
 ³7KHVHUHVXOWVLPSO\WKDWWKHSUHYLRXVOLWHUDWXUHKDVXQGHUHVWLPDWHGWKH
medical costs of obesity, resulting in underestimates of the economic 
rationale for government intervention to reduce obesity-related 
H[WHUQDOLWLHV´
 However, could it be that genes that affect weight may also directly 
affect medical costs, or lie next to genes that directly affect medical 
costs?
Bockerman et al (2016)
 Bockerman et al (2016) used IV to investigate the impact of obesity on 
labour market outcomes (earnings, employment and social income 
transfers)
 Problem:  Obesity is likely to be associated with other factors, 
including rate of time preference, that affect medical costs (X3s)
± Also, reverse causality if low income results in weight gain
 6ROXWLRQ,QVWUXPHQW]IRULQGLYLGXDO¶VERG\ZHLJKWZDVDQJHQHWLF
risk factor score based on 32 SNPs shown to influence obesity
 Instrument validity:  Authors appealed to existing research showing 
no relationship between the 32 BMI-related SNPs and intelligence
 The negative impact of weight on labour market outcomes appeared to 
be larger in the IV analysis
Warning!
³$OWKRXJKWKHDSSHDORI,9DVDPHWKRGIRUDGGUHVVLQJHQGRJHQHLW\
issues is undeniable, it is important to understand that the use of IV 
can do more harm than good.
³5DWKHUFRPPRQ«DUHKHURLFDWWHPSWVWRµILQGDQLQVWUXPHQW¶
ZKHQHYHUWKHVOLJKWHVWSRVVLELOLW\RIHQGRJHQHLW\DULVHV´
Pitfalls
 Validity of the instrument
± Just as the researcher never really knows how big the endogeneity 
problem is, nor can the validity of the instrument ever be proven
± Vital that researcher appeals to existing theory or empirical 
evidence to make a convincing case
± Falsification tests may be helpful, but still do not provide conclusive 
evidence
 In an effort to ensure the validity of the instrument, researchers may 
have a tendency to use weak instruments, i.e. weak correlation between 
Z and X1
± Large standard errors
± Biased towards the OLS estimates if small sample size
± Vital that researchers:
 Report the first stage F statistics
 Use a large sample size
Heterogeneous treatment effects
 IV parameters represent the Local Average Treatment Effect (LATE) ± that is 
the average (causal) effect of X on Y for those whose treatment status has been 
changed by the instrument (i.e. µFRPSOLHUV¶)
± This is because the estimates were identified through independent variation 
induced only by the chosen instrument(s)
 e.g. in the McClellan (1994) study, the compliers are heart attack 
patients for whom the choice of hospital is affected by the differential 
distance to the specialist hospital
± No information about µDOZD\V-WDNHUV¶ and µQHYHU-WDNHUV¶since they 
always/never take the treatment independently of Z
 e.g. patients who will always (or never) attend the specialist hospital 
regardless of the differential distance
 LATE also assumes that there were no µdefiers,¶LHDOWKRXJKWKHLQVWUXPHQW
need not have affected everyone, those who were affected were affected in the 
same way (monotonicity)
 e.g. patients whose treatment is changed by the instrument would 
always be more (not less) likely to attend the specialist hospital as the 
differential distance decreases
Why is IV necessary in the first 
place?
 Author must explain why IV is necessary
 If the potential bias of single equation method is of a small magnitude, 
then the loss of precision in IV estimates might not be justified
± In some case better to report IV results as a sensitivity analysis?
± Discussion of the expected direction of the bias in OLS estimates 
may be sufficient to inform policy making
 Unlike RCTs, IVs may take some explaining for policy makers?
The future of IV in health economics
 IV likely to remain popular
± Increasing size and availability of panel datasets with variables 
across multiple domains, e.g. health, education, labour market, 
family history, etc.
± Increased potential for data linkage across sectors, e.g. diverse 
administrative datasets and local geographic data related to the 
social determinants of health
± Increased availability of genetic data
 Recent MRC guidance on natural experiments 
highlights IVs
 The main challenges are not technical, but in 
identifying good sources of natural experiments
 Good practice guidance for authors and reviewers 
of studies is vital to avoid erroneous interpretation
³'RZHKDYHDPHWKRGWRFRQWUROIRUERWKREVHUYHGDQGXQREVHUYHGELDV"
³7KHDQVZHULVµWKHRUHWLFDOO\<(6¶EXWSUDFWLFDODSSOLFDWLRQLVYHU\
OLPLWHGEHFDXVHRIWKHGLIILFXOW\LQILQGLQJWKHULJKWLQVWUXPHQW´
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